Technical Papers

711 Results

Patient-Centric Drug-Development Process

Patient-Centric Drug-Development Process

Content provided by Catalent | 28-Nov-2016 | Insight Guide

For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both...

Choosing the Right Size Sphere

Choosing the Right Size Sphere

Content provided by Colorcon Inc. | 21-Nov-2016 | White Paper

Choosing the right size sugar sphere, for a multiparticulate dosage form is imperative.  Size matters; not only to achieve a robust formulation and efficient...

Tailoring the autoinjection with SAFELIA®

Tailoring the autoinjection with SAFELIA®

Content provided by Nemera | 21-Nov-2016 | White Paper

For a better patient experience and for an optimized drug deliver, including for high volumes high viscosities formulation.Safelia injection course can...

Experience foam for topical drug delivery

Experience foam for topical drug delivery

Content provided by Gattefossé | 14-Nov-2016 | White Paper

Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate...

Elemental Impurities Regulations View from a CRO

Elemental Impurities Regulations View from a CRO

Content provided by RSSL | 02-Nov-2016 | White Paper

Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United...

pH measurement: Six technical tips

pH measurement: Six technical tips

Content provided by Metrohm – customized analysis for the pharmaceutical industry | 10-Oct-2016 | White Paper

The pH value is one of the most important and therefore also one of the most frequently measured quantities in analytical chemistry. Sometimes a simple...

The Time for Supply Chain Transformation Has Come

The Time for Supply Chain Transformation Has Come

Content provided by Catalent | 26-Sep-2016 | Insight Guide

Adaptive protocol designs, shrinking trial sizes and a growing focus on patients are just a few of the clinical trial trends and recent innovations that...

FDA Focus̶ Product Design and Post Approval Changes

FDA Focus̶ Product Design and Post Approval Changes

Content provided by Colorcon Inc. | 19-Sep-2016 | White Paper

Review a new Colorcon Technical Paper offering a summary of key points presented in the recent US Center for Drug Evaluation and Research (CDER) Guidance...

Excellence in Pharmaceutical Analysis

Excellence in Pharmaceutical Analysis

Content provided by Butterworth | 16-Sep-2016 | Data Sheet

Butterworth specialise in Quality Control Analysis, Method Development, Validation & Stability Testing of Raw Materials, API, Finished Product and...

SGS-LSS

Amino Acid Analysis of Pharmaceutical Products

Content provided by SGS Life Science Services | 11-Jul-2016 | White Paper

Amino Acid Analysis in general can be used for identification testing of biopharmaceutical active ingredients and the determination of impurities and related...

baxter_smartlead_downloadPage_image

Building the Future: Using Simulation Effectively

Content provided by Baxter BioPharma Solutions | 09-May-2016 | Case Study

This case study provides an in-depth look at Baxter BioPharma Solutions’ latest expansion at their Halle, Germany cytotoxic facility, offering insight...

New Organic Coating System to Modulate Drug Release

New Organic Coating System to Modulate Drug Release

Content provided by Colorcon Inc. | 09-May-2016 | White Paper

A Colorcon Study, Effect of Coating Weight Gain and Pore-Former Level on Drug Release with a Fully Formulated Ethylcellulose Barrier Membrane Coating System,...

Human study: gelatin & HPMC capsule bioequivalence

Human study: gelatin & HPMC capsule bioequivalence

Content provided by Capsugel | 04-May-2016 | White Paper

Rapid and consistent in-vivo drug dissolution is critical for drug absorption. However, in-vitro dissolution results do not always correlate with the in-vivo...

Abbott_Whitepaper-Considerations-in-purchasing-a-LIMS_Web

Considerations in Purchasing a LIMS

Content provided by Abbott Informatics | 27-Apr-2016 | White Paper

Many scientific enterprises find themselves in need of a Laboratory Information Management System (LIMS) to replace an incumbent system, whether an existing...

SGS-sputum

Respiratory Patient Clinical Trials

Content provided by SGS Life Science Services | 25-Apr-2016 | White Paper

This white paper will examine the use of sputum induction as a pharmacodynamic method to optimize respiratory patient clinical trials, including comparison...

Data Mining At The FDA

Data Mining At The FDA

Content provided by Oracle Health Sciences | 20-Apr-2016 | White Paper

The FDA has recommended the use of data mining to the drug industry, and their new Data Mining at FDA white paper summarizes their past and current data...

What do you need to know about Direct-To-Patient

What do you need to know about Direct-To-Patient

Content provided by World Courier | 18-Apr-2016 | White Paper

In the world of clinical trials, one of the greatest challenges to overcome is the recruitment and retention of qualified patients. Finding patients who...

Single-Pass TFF and the New Era of Bioprocessing

Single-Pass TFF and the New Era of Bioprocessing

Content provided by Pall Biotech | 11-Apr-2016 | White Paper

Learn how single-pass tangential flow filtration (SPTFF) technology is revolutionizing current and future bioprocessing platforms with its implementations...

Orphan Drugs make all the difference to patients

Orphan Drugs make all the difference to patients

Content provided by World Courier | 22-Mar-2016 | White Paper

Orphan drugs, those medications that are typically produced in small quantities for limited patient populations, are growing in importance worldwide. Once...

White paper: ensure quality in novel dosage forms

White paper: ensure quality in novel dosage forms

Content provided by Stable Micro Systems | 14-Mar-2016 | White Paper

From oral sprays to pastilles and capsules, pharmaceutical products must increasingly cater for a wider range of preferences. Download this free white...

Recipharm

SERIALISATION

Content provided by Recipharm AB | 10-Mar-2016 | White Paper

Recipharm already has experience in serialised production. From our UK facility in Manchester over 40 batches have been delivered from a fully validated...

Can patient-centric innovation transform PV

Can patient-centric innovation transform PV

Content provided by Sciformix | 08-Mar-2016 | White Paper

The importance of Pharmacovigilance (PV) as a science and its role in effective patient care in clinical practice and public health is growing. Patient-centeredness...

High energetic and Phosgene reactions in safe hands

High energetic and Phosgene reactions in safe hands

Content provided by Valsynthese SA | 01-Mar-2016 | White Paper

Valsynthese, expert in high energetic and hazardous fine chemical production of key intermediates and APIs, is devoted to delivering high quality services...

World Courier tackles the last mile challenge

World Courier tackles the last mile challenge

Content provided by World Courier | 18-Jan-2016 | Research Study

The global pharmaceutical industry will have spent more than $10 billion on cold chain logistics in 2015, getting products and clinical trial supplies...

Leveraging ADVASEPT® Technology

Leveraging ADVASEPT® Technology

Content provided by Catalent | 14-Dec-2015 | Case Study

Catalent’s ADVASEPT® Technology is an advanced aseptic manufacturing process that leverages blow-fill-seal (BFS) technology to create a glass free container...

How did 2015 unfold in specialty logistics?

How did 2015 unfold in specialty logistics?

Content provided by World Courier | 07-Dec-2015 | Case Study

It’s time to look back and see how our predictions for this year fared, and take another look at the things we have written about since then.We examine...

Critical Logistics: When there is no margin for error

Critical Logistics: When there is no margin for error

Content provided by World Courier | 17-Nov-2015 | White Paper

Rare diseases can affect as few as one in a million people, but for those unfortunate enough to experience them, medication therapy is often their only...

Follow us

Products

View more

Webinars